Toggle navigation
Home
Search
Services
Blog
Contact
About
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne
Abgenix, Inc., Fremont, CA, United States
Search 27 grants from Anne Messer
Search grants from Abgenix, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Acceptability and feasibility of Community-based mHealth Motivational Interviewing Tool for Depression (COMMIT-D) to improve adherence to treatment
Cerebral arteriole structure/function in diabetic ischemic brain injury
Sparsely Sampled 3D EPSI and Compressed Sensing Reconstruction of HIV Adults
Interactions of C3 with Immunoglobulin G- Regulation of C3 Function by Antibody
Regulation of Ige Synthesis in Man
Recently added grants:
Injury-Induced Pain: Chemical Modulation of Nociceptors
Dendrite morphogenesis, function and regeneration
Myoferlin in muscle membrane fusion and repair
Summer Research Experiences in Neurological Dysfunction
University of California San Diego Neuroscience Microscopy Imaging Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
7R42NS038002-03
Application #
6351866
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Oliver, Eugene J
Project Start
1998-08-01
Project End
2003-01-31
Budget Start
2001-02-01
Budget End
2003-01-31
Support Year
3
Fiscal Year
2001
Total Cost
$250,000
Indirect Cost
Institution
Name
Abgenix, Inc.
Department
Type
DUNS #
City
Fremont
State
CA
Country
United States
Zip Code
94555
Related projects
NIH 2001
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Abgenix, Inc.
$250,000
NIH 2000
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Intraimmune Therapies, Inc.
$250,000
Comments
Be the first to comment on Anne Messer's grant